Search results
Here's Why Demand for Ozempic and Wegovy Could Soar Even Higher
Motley Fool via Yahoo Finance· 4 days agoOdds are that if you hear the word "Ozempic," you likely associate that with weight loss. It's hard...
The U.S. is fighting high drug prices. Big Pharma isn't sweating — yet
Quartz· 2 days agoA key goal of the Biden administration has been to rein in healthcare costs. As the administration...
Is This Trend a Threat to Eli Lilly's Weight Loss Drug Dominance?
Motley Fool via Yahoo Finance· 5 days agoMounjaro and Zepbound are the same drug -- tirzepatide -- but marketed under two different names....
Here's Why Demand for Ozempic and Wegovy Could Soar Even Higher
The Motley Fool via AOL· 4 days agoOdds are that if you hear the word "Ozempic," you likely associate that with weight loss. It's hard not to given all the posts on social media about users losing weight thanks to the
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
Motley Fool via Yahoo Finance· 3 days agoRight now, it can probably afford to run confirmatory clinical trials or even gather more data from...
Abbott secures FDA clearance for two over-the-counter glucose monitors
Reuters· 2 days ago, opens new tab said on Monday the U.S. health regulator had cleared the company's two new over-the-counter glucose monitoring devices, expanding its presence in a fast-growing ...
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Reuters via Yahoo News· 2 days agoEvidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart...
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
The Motley Fool via AOL· 3 days agoRight now, it can probably afford to run confirmatory clinical trials or even gather more data from new trials to allay concerns that regulators may have during the approval ...
Why Is Biomea Fusion (BMEA) Stock Down 63% Today?
InvestorPlace· 5 days agoBiomea Fusion (NASDAQ:BMEA) stock is falling hard on Friday after announcing a clinical hold has been put on its Phase I/II clinical trials of BMF-219....
Is Amgen Inc (NASDAQ:AMGN) the Top Dividend Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 1 day agoWe recently published a list of Top Dividend Stocks to Buy in 2024 According to Billionaire Paul...